CALLING ALL VIVUS LONGS!
I have 2 very informative posts for you all! The first is news after the bell--read the last paragraph and the second will be a post from the Vivus Yahoo board:
Message Boards Help - Edit Public Profile - Personalize - SignÿOut
Top:Business and Finance:Stocks:Healthcare:Biotechnology & Drugs:VVUS (Vivus, Inc.)
<- Previous Next -> Message 8858 of 8863 Reply
Vivus developing its own pill for ED davidpaul98
Jun 2 1998
4:49PM EDT
Be sure to read the last paragraph...
Vivus Inc. Sees 2Q Loss Wider Than 1Q Loss 7c/Shr
NEW YORK (Dow Jones)--Vivus Inc. (VVUS) expects its second-quarter loss will be wider than the 7 cents a share it reported in the first quarter, according to Chief Financial Officer David Yntema.
Analysts surveyed by First Call Corp. expect the company to lose 15 cents in the second quarter, compared with year-earlier earnings of 28 cents.
Addressing the PaineWebber Growth & Technology Conference here, Yntema said the launch of Pfizer Inc.'s (PFE) impotence pill Viagra has caused prescriptions for Vivus' Muse urethral suppository, which also treats erectile dysfunction, to decline by two-thirds. That decline appears to be bottoming out, according to Yntema.
Despite the intense competition it has provided, Viagra has also brought blessings to the market, increasing awareness of erectile dysfunction and significantly expanding the market.
Muse itself caused something of an uproar when it was launched in 1997. It quickly became the therapy prescribed most often by urologists for erectile dysfunction, making it one of the top 35 most successful first-year pharmaceutical products.
Despite patients' obvious preference for taking a pill versus using a urethral suppository, Yntema said Muse will ultimately differentiate itself from Viagra by positioning itself as the first-line therapy for patients with moderate to severe erectile dysfunction. Muse can also safely be used by those taking nitrates to treat heart disease. Pfizer recently reported six patients taking Viagra died likely because they combined the drug with such heart disease medication.
Yntema said Vivus is working on additional treatments for erectile dysfunction, including its own pill. The company also hopes to develop treatments for incontinence and sexual dysfunction, including premature ejaculation.
ÿ
VVUS:ÿ Quote ÿ|ÿ Profile ÿ|ÿResearch This Is a Reply to: Msg 8857 by newtrash
<- Previous Next -> Message 8858 of 8863 Reply
ÿÿ
--------------------------------------------------------------------------------
Go to: Startÿ|ÿMost Recentÿ|ÿMessage List | Message Number:ÿ ÿ
ÿ
--------------------------------------------------------------------------------
Terms and Conditions
Yahoo! is a trademark of Yahoo! Inc.
Copyright c 1994-98 Yahoo! All Rights Reserved. |
